Anticonvulsants to treat idiopathic restless legs syndrome: Systematic review

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 2 B, 2008, Pages 431-435

  Conti, Cristiane Fiquene ^a,b   De Oliveira, Márcio Moysés ^a,b   Valbuza, Juliana Spelta ^a,b   Prado, Lucila Bizari F ^a   De Carvalho, Luciane Bizari Coin ^a   Prado, Gilmar Fernandes Do ^a,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Brazilian Cochrane Center

^c Brazilian Cochrane Center ^*  (Brazil)

Author keywords

Anticonvulsant; Restless legs

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; CARBAMAZEPINE; GABAPENTIN; PLACEBO; VALPROIC ACID;

ABDOMINAL PAIN; BEDTIME DOSAGE; CLINICAL PRACTICE; CLINICAL TRIAL; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; GASTRITIS; HEADACHE; HUMAN; MALAISE; META ANALYSIS; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SIDE EFFECT; SLEEP; SLEEP DISORDER; SWEATING; SYMPTOM; SYSTEMATIC REVIEW; VOMITING;

EID: 47749083512     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000300034     Document Type: Review

References (27)

1. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome review. Lancet Neurol 2005;4:465-475.
2. Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005;28:891-898.
3. Teive HA, Quadros A, Barros FC, Werneck LC. Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report. Arq Neuropsiquiatr 2002;60:1025-1029.
4. Pimenta AM. Pernas inquietas: estudo de uma família. Comunicações correlatas e livres do V Congresso Brasileiro de Neurologia. Arq Neuropsiquiatr 1972;resumos:100.
5. Goffredo GS Filho, Gorini CC, Purysko AS, Silva HC, Elias IE. Restless legs syndrome in patients on chronic hemodialysis in a Brazilian city: frequency, biochemical findings and comorbidities. Arq Neuropsiquiatr 2003;61:723-727.
6. Grupo Brasileiro de Estudos em Síndrome das Pernas Inquietas. Restless legs syndrome: diagnosis and treatment. Opinion of Brazilian experts. Arq Neuropsiquiatr 2007;65:721-727.
7. Ondo W,Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology 1996;47:1435-1441.
8. Allen RP. Dopamine and iron in the pathophysiology of restless legs syndrome. Sleep Med 2004;5:385-391
9. Pugsley TA, Whetzel SZ, Dooley DJ. Reduction of 3,4-diaminopyridine- induced biogenic amine synthesis and release in rat brain by gabapentin. Psychopharmacology 1998;137:74-80.
10. American Sleep Disorders Association. The international classification of sleep disorders: diagnostic and coding manual. Revised Edition. Rochester, MN: American Sleep Disorders Association 1997
11. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-109.
12. The International Restless Legs Syndrome Study Group. Validation of The International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132.
13. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002;31:140-149.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177-188.
15. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
16. Borreguero GD, Larrosa O, LlaveY, VergerK, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin. Neurology 2002;59:1573-1579.
17. Testald W, Sorensen O, Larsen S, Lillevold PE, Stensrud P, Hanssen RN. Treatment of restless legs syndrome with carbamazepine: a double blind study. BMJ 1984;288:444-446.
18. Lundvall O, Abom PE, Holm R. Carbmazepine in Restless Legs Syndrome. Eur J Clin Pharmacol 1983;25:323-324.
19. Eisensehr I, Ehrenberg BL, Rogge Solti S, Noachtar S. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid. J Neurol 2004;5:579-583.
20. Adler CH. Clin Neuropharmacol 1997;20:148-151.
21. Bravo AP. Utilidad del topiramato en el tratamiento del síndrome de piernas inquietas. Actas Esp Psiquiatr 2004;32:132-137.
22. Happe S, Klösch G, Saletu B, Zeitlhofer J. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 2001;57:1717-1719.
23. Happe S, Saulter C, Klosh G, Saletu B. Gabapentin versus ropinirole in the treatment of idiophatic restless legs syndrome. Neuropsychobiology 2003;48:82-86.
24. Youssef EA, Wagner ML, Martinez JO, Hening W. Pilot trial of lamotrigine in the restless legs syndrome. Sleep Med 2005;6:89.
25. Zuconni M, Coccagna G, Petronelli R, Gerardi R, Mondini S, Cirignotta F. Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment. Functional Neurol 1989;4:263-271.
26. Sorensen O, Testald W. Carbamazepin (Tegretol) ved restless legs syndrome. Tidsskr Nor Laegeforen 1984;104:2093-2095.
27. Allen RP,Earley CJ. Augmentation of the restless legs syndrome with carbidopa levodopa. Sleep 1996;14:629-650.